Tissue engineering and 3D bioprinting are among the modern technologies contributing to the advancement of regenerative medicine. They aim to repair damaged tissues or replace lost tissues by combining living cells, biomaterials, and growth factors. These technologies represent an important step toward developing innovative treatments and reducing reliance on donated organs. The Concept of Tissue Engineering and Bioprinting Tissue engineering relies on three fundamental components: living cells, biological scaffolds that support cell growth, and factors that promote cell proliferation and differentiation. Bioreactors are used to provide suitable conditions for tissue growth and maturation. Three-dimensional bioprinting, on the other hand, involves depositing cells and biomaterials, known as bioinks, according to a specific digital design to produce structures that mimic the architecture of natural tissues. Major Techniques and Applications Several bioprinting techniques are available, including extrusion-based printing, inkjet printing, and laser-assisted printing. The appropriate technique is selected according to the type of tissue required and the desired level of fabrication precision. Key medical applications include producing skin substitutes for treating burns and chronic wounds, supporting bone and cartilage repair, and developing tissue models for drug testing and studying cellular responses to different treatments. Advanced research is also being conducted to engineer more complex tissues, such as those of the heart, liver, and kidneys. Advantages and Challenges These technologies offer the possibility of designing tissues tailored to individual patient needs. They may also help reduce immune rejection when the patient’s own cells are used, support personalized medicine, and reduce reliance on animal testing in certain stages of drug development. Despite these advantages, several scientific and technical challenges remain. These include establishing vascular networks within thick tissues, maintaining cell viability during printing, achieving functional tissue maturation, and addressing high manufacturing costs. Strict quality and safety standards are also essential to ensure the reliability of these technologies. Future Prospects and Innovations Current research focuses on developing printable vascular networks, integrating artificial intelligence to optimize bioink design and printing accuracy, and exploring in situ bioprinting, which involves printing tissues directly at the site of injury. These developments are expected to expand the medical applications of bioprinting in the future, although further research and clinical trials are necessary to establish their safety and effectiveness. Conclusion Tissue engineering and 3D bioprinting represent promising fields in regenerative medicine, offering new possibilities for tissue repair and the development of patient-specific biological substitutes. With continued scientific and technological progress, these innovations may contribute to improving healthcare quality. However, the fabrication of fully functional and complex human organs remains a major research challenge. Al-Mustaqbal University — The No. 1 University in Iraq.